GT Biopharma, Inc. (NASDAQ: GTBP) is a clinical stage immuno-oncology company focused on developing innovative therapies based on the Company's proprietary NK cell engager (TriKE®) technology. TriKE® therapeutic agents are targeted immunotherapeutic agents that simultaneously react with natural killer (NK) cells and cancer cells to selectively facilitate the killing of cancer cells.
Profile
Business Description
Company Info
Address:
8000 Marina Blvd
Suite 100
Brisbane, CA 94005
Email:
info@gtbiopharma.com
Industry Classifications
Sector:
Healthcare
Industry:
Medical Diagnostics & Research
NAICS:
Pharmaceutical Preparation Manufacturing (325412)
SIC:
Pharmaceutical Preparations (2834)